Vipan Taneja is a highly skilled Principal Scientist at Bristol Myers Squibb, bringing over 20 years of extensive pharmaceutical experience to the table. His expertise lies in analytical science, where he has established himself as a Subject Matter Expert (SME) in managing project deliverables across...
Vipan Taneja is a highly skilled Principal Scientist at Bristol Myers Squibb, bringing over 20 years of extensive pharmaceutical experience to the table. His expertise lies in analytical science, where he has established himself as a Subject Matter Expert (SME) in managing project deliverables across multiple assets, guiding them from clinical development through to commercial filing and approval. Vipan’s meticulous attention to detail and quality focus are evident in his adeptness at writing and reviewing critical analytical documents, including methods, protocols, validation reports, and stability reports, ensuring compliance with FDA regulations and 21 CFR Part 11 standards.
In his current role, Vipan plays a pivotal part in multi-disciplinary and interdepartmental teams, collaborating with external partners to support formulation development and analytical method development. His experience encompasses method transfer and outsourced analytical testing, where he leverages his critical thinking and decision-making skills to navigate complex challenges and ensure that project timelines are consistently met. Vipan's proficiency in High-Performance Liquid Chromatography (HPLC) and Good Laboratory Practice (GLP) further enhances his ability to deliver high-quality results in drug development processes.
Vipan is also well-versed in Chemistry, Manufacturing, and Controls (CMC) authoring, which involves regulatory interactions that are crucial for successful product submissions. His commitment to excellence and his comprehensive understanding of the pharmaceutical landscape make him an invaluable asset to Bristol Myers Squibb, where he continues to drive innovation and quality in analytical science.
